Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin
暂无分享,去创建一个
F. Baquero | J. García de Lomas | R. Cantón | J. Martínez-Beltrán | C. Gimeno | F. Tubau | J. Liñares
[1] M. Jacobs,et al. Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin , 1994, Antimicrobial Agents and Chemotherapy.
[2] S. Brown,et al. In-vitro activity of cefepime and other antimicrobials: survey of European isolates. , 1993, The Journal of antimicrobial chemotherapy.
[3] A. Ehrhardt,et al. β-Lactam resistance amongst Enterobacter species , 1993 .
[4] D. Livermore,et al. Effects of β-lactamase induciblilty and derepression on the activity of cefepime and cefpirome against Gram-negative bacteria , 1993 .
[5] R. Jones,et al. Antimicrobial activity of FK-037 against class I beta-lactamase producing species resistant to ceftazidime: a multi-laboratory clinical isolate sample. , 1993, The Journal of antimicrobial chemotherapy.
[6] P. Murray,et al. Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime , 1993, Antimicrobial Agents and Chemotherapy.
[7] H. Neu,et al. In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin , 1993, Antimicrobial Agents and Chemotherapy.
[8] B. Foleno,et al. In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporin , 1993, Antimicrobial Agents and Chemotherapy.
[9] Y. Matsumoto,et al. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin. , 1993, The Journal of antibiotics.
[10] R. Jones,et al. Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers. , 1991, Diagnostic microbiology and infectious disease.
[11] I. Phillips,et al. Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins , 1990, European Journal of Clinical Microbiology and Infectious Diseases.
[12] F. J. DeOrio,et al. Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels , 1989, Antimicrobial Agents and Chemotherapy.
[13] R. Jones,et al. In-vitro activity of FK-037, a new parenteral cephalosporin. , 1994, The Journal of antimicrobial chemotherapy.
[14] N. Rolando,et al. The penetration of imipenem/cilastatin into ascitic fluid in patients with chronic liver disease. , 1994, The Journal of antimicrobial chemotherapy.
[15] R. Hancock,et al. Factors involved in the enhanced efficacy against gram-negative bacteria of fourth generation cephalosporins. , 1992, The Journal of antimicrobial chemotherapy.
[16] R. Jones,et al. Activity of cefepime (BMY-28142) and cefpirome (HR 810) against gram-negative bacilli resistant to cefotaxime or ceftazidime. , 1989, The Journal of antimicrobial chemotherapy.